Hospital Prescribing, England - 2012
Please note: on 26 November 2013 an updated version of the report was uploaded to correct an error in the data presented for England in Table 3 of the report. All SHA figures in this table were correct and remain the same. This was due to a production error by the HSCIC.
This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year are anti-bacterial drugs (BNF Section 5.1).
The overall NHS expenditure on medicines in 2012 was £13.3 billion.
In 2012 hospital use accounted for 36.5 per cent of the total cost, up from 33.3 per cent in 2011.
The cost of medicines rose by 1.5 per cent overall but by 11.1 per cent in hospitals.
Of the drugs positively appraised by NICE, the greatest overall cost was for adalimumab, which also incurred the greatest cost in hospitals.
Related linksReturn to Find data
Can't find what you need? Please email our Contact Centre for assistance.
You can also Have Your Say about our statistical publications.
- Publications Calendar
- Supporting transparency and open data
- Data quality
- Statement of administrative sources
- Methodological changes
- International statistics
- Aligning statistics to the new health landscape
- Ordering printed materials
- Guide to Confidentiality in Health and Social Care
- Publication strategy
- Adult Social Care Outcomes Framework (ASCOF)
- Hospital Estates and Facilities Statistics
- Indicator Portal
- National Adult Social Care Intelligence Service
- NHS Safety Thermometer
- All tools
- Contact us via 0300 303 5678 or email firstname.lastname@example.org